Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
41.00
+0.09 (0.22%)
At close: Apr 24, 2024, 4:00 PM
40.21
-0.79 (-1.93%)
After-hours: Apr 24, 2024, 4:32 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AMPH stock have an average target of 59.25, with a low estimate of 44 and a high estimate of 70. The average target predicts an increase of 44.51% from the current stock price of 41.00.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2024.
Analyst Ratings
The average analyst rating for AMPH stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $60 | Buy | Initiates | $60 | +46.34% | Mar 5, 2024 |
| B of A Securities | B of A Securities | Hold Initiates $63 | Hold | Initiates | $63 | +53.66% | Nov 17, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +70.73% | Jul 25, 2023 |
| Wells Fargo | Wells Fargo | Hold Maintains $40 → $44 | Hold | Maintains | $40 → $44 | +7.32% | May 17, 2023 |
Financial Forecast
Revenue This Year
754.18M
from 644.40M
Increased by 17.04%
Revenue Next Year
829.40M
from 754.18M
Increased by 9.97%
EPS This Year
3.83
from 2.60
Increased by 47.38%
EPS Next Year
4.41
from 3.83
Increased by 15.22%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 835.8M | 935.6M | 1.1B | 1.3B |
| Avg | 754.2M | 829.4M | 902.4M | 1.2B |
| Low | 519.4M | 562.5M | 592.9M | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 29.7% | 24.0% | 36.2% | 40.6% |
| Avg | 17.0% | 10.0% | 8.8% | 36.6% |
| Low | -19.4% | -25.4% | -28.5% | 31.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.75 | 5.37 | 6.17 | 7.11 |
| Avg | 3.83 | 4.41 | 5.10 | 6.91 |
| Low | 3.06 | 3.33 | 3.64 | 6.63 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 82.5% | 40.0% | 39.8% | 39.3% |
| Avg | 47.4% | 15.2% | 15.6% | 35.3% |
| Low | 17.6% | -13.0% | -17.6% | 30.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.